Tuberculosis drug discovery: A decade of hit assessment for defined targets

S Oh, L Trifonov, VD Yadav, CE Barry III… - Frontiers in Cellular …, 2021 - frontiersin.org
More than two decades have elapsed since the publication of the first genome sequence of
Mycobacterium tuberculosis (Mtb) which, shortly thereafter, enabled methods to determine …

[HTML][HTML] Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases

SIR Okoduwa, I Abdulwaliyu, BE Igiri, SO Arekemase… - Phytomedicine Plus, 2024 - Elsevier
Background Diseases are one of the factors affecting human and national development in
all its ramifications. Some of the diseases that affect humans are usually difficult to manage …

[HTML][HTML] Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review

AA Rabaan, S Alhumaid, H Albayat, M Alsaeed… - Molecules, 2022 - mdpi.com
Tuberculosis (TB) caused by the bacterial pathogen Mycobacterium tuberculosis (Mtb)
remains a threat to mankind, with over a billion of deaths in the last two centuries. Recent …

Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discovery

G Cazzaniga, M Mori, LR Chiarelli, A Gelain… - European journal of …, 2021 - Elsevier
For centuries, natural products (NPs) have served as powerful therapeutics against a variety
of human ailments. Nowadays, they still represent invaluable resources for the treatment of …

[HTML][HTML] Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis

MC Martini, T Zhang, JT Williams… - Journal of …, 2020 - Elsevier
Ethnopharmacological relevance Emergence of drug-resistant and multidrug-resistant
Mycobacterium tuberculosis (Mtb) strains is a major barrier to tuberculosis (TB) eradication …

Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective

P Prasher, M Sharma, M Mehta, KR Paudel… - Chemico-biological …, 2020 - Elsevier
The apparent predicament of the representative chemotherapy for managing respiratory
distress calls for an obligatory deliberation for identifying the pharmaceuticals that effectively …

Combatting antimicrobial resistance via the cysteine biosynthesis pathway in bacterial pathogens

JL Hicks, KEA Oldham, J McGarvie… - Bioscience …, 2022 - portlandpress.com
Antibiotics are the cornerstone of modern medicine and agriculture, and rising antibiotic
resistance is one the biggest threats to global health and food security. Identifying new and …

Antimicrobial activity of compounds identified by artificial intelligence discovery engine targeting enzymes involved in Neisseria gonorrhoeae peptidoglycan …

R Kant, H Tilford, CS Freitas, DAS Ferreira, J Ng… - Biological Research, 2024 - Springer
Abstract Background Neisseria gonorrhoeae (Ng) causes the sexually transmitted disease
gonorrhoea. There are no vaccines and infections are treated principally with antibiotics …

Targeting dormant phenotype acquired mycobacteria using natural products by exploring its important targets: In vitro and in silico studies

S Sharma, R Chikhale, N Shinde, AM Khan… - Frontiers in Cellular …, 2023 - frontiersin.org
The dormant phenotype of Mycobacterium tuberculosis that develops during infection poses
a major challenge in disease treatment, since these bacilli show tolerance to front-line …

The impact of pulmonary tuberculosis on immunological and metabolic features of diabetic patients

H Chen, L Su, J Bao, K Zhang, Y Li, E Mao - Frontiers in Immunology, 2022 - frontiersin.org
Impaired immune responses have been observed in patients with type-2 diabetes mellitus
(T2DM), which increases susceptibility to tuberculosis infection. However, the effect of the …